Oramed Pharmaceuticals Inc. (TLV:ORMP)

Oramed Pharmaceuticals Statistics

Total Valuation

TLV:ORMP has a market cap or net worth of ILS 295.57 million. The enterprise value is -34.45 million.

Market Cap	295.57M
Enterprise Value	-34.45M

Important Dates

The last earnings date was Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	41.00M
Shares Outstanding	n/a
Shares Change (YoY)	-0.21%
Shares Change (QoQ)	+3.35%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	32.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	43.86
PB Ratio	0.57
P/TBV Ratio	0.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.42
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.64

Financial Position

The company has a current ratio of 26.81, with a Debt / Equity ratio of 0.01.

Current Ratio	26.81
Quick Ratio	26.69
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -14.69% and return on invested capital (ROIC) is -5.16%.

Return on Equity (ROE)	-14.69%
Return on Assets (ROA)	-4.94%
Return on Invested Capital (ROIC)	-5.16%
Return on Capital Employed (ROCE)	-8.65%
Revenue Per Employee	1.68M
Profits Per Employee	-20.35M
Employee Count	4
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, TLV:ORMP has paid 6.76 million in taxes.

Income Tax	6.76M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.36% in the last 52 weeks. The beta is 1.60, so TLV:ORMP's price volatility has been higher than the market average.

Beta (5Y)	1.60
52-Week Price Change	-18.36%
50-Day Moving Average	729.72
200-Day Moving Average	807.11
Relative Strength Index (RSI)	47.41
Average Volume (20 Days)	7,574

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.35

Income Statement

In the last 12 months, TLV:ORMP had revenue of ILS 6.74 million and -81.41 million in losses. Loss per share was -2.03.

Revenue	6.74M
Gross Profit	43,801
Operating Income	-46.07M
Pretax Income	-74.85M
Net Income	-81.41M
EBITDA	-45.59M
EBIT	-46.07M
Loss Per Share	-2.03

Balance Sheet

The company has 329.99 million in cash and 3.07 million in debt, giving a net cash position of 326.92 million.

Cash & Cash Equivalents	329.99M
Total Debt	3.07M
Net Cash	326.92M
Net Cash Per Share	n/a
Equity (Book Value)	517.47M
Book Value Per Share	12.75
Working Capital	321.21M

Cash Flow

In the last 12 months, operating cash flow was -54.13 million and capital expenditures -77,494, giving a free cash flow of -54.21 million.

Operating Cash Flow	-54.13M
Capital Expenditures	-77,494
Free Cash Flow	-54.21M
FCF Per Share	n/a

Margins

Gross Margin	0.65%
Operating Margin	-683.65%
Pretax Margin	-1,110.80%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TLV:ORMP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.21%
Shareholder Yield	n/a
Earnings Yield	-27.54%
FCF Yield	-18.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TLV:ORMP has an Altman Z-Score of 5.98 and a Piotroski F-Score of 1.

Altman Z-Score	5.98
Piotroski F-Score	1